王者荣耀直播app下载网址

AbbVie traded at $141.42 this Friday September 9th, increasing $0.90 or 0.64 percent since the previous trading session. Looking back, over the last four weeks, AbbVie gained 0.34 percent. Over the last 12 months, its price rose by 32.56 percent. Looking ahead, we forecast AbbVie to be priced at 132.36 by the end of this quarter and at 121.25 in one year, according to 王者荣耀电竞(江西)积分排榜 global macro models projections and analysts expectations.

Stock Price
141.42
Daily Change
0.64%
Yearly
32.56%

Ok
王者荣耀电竞(江西)积分排榜 members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The 王者荣耀电竞(江西)积分排榜 Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Eisai 5,918.00 121.00 2.09% -28.70%
AbbVie 141.42 0.90 0.64% 32.56%
Abbott 108.48 1.49 1.39% -15.78%
ALKERMES 24.01 -0.05 -0.21% -21.33%
Amgen 247.69 2.24 0.91% 15.88%
AstraZeneca 10,500.00 -12.00 -0.11% 28.47%
Astrazeneca 60.85 0.53 0.88% 8.16%
Biogen 211.84 3.86 1.86% -29.34%
BioMarin Pharmaceutical 92.93 -0.08 -0.09% 19.17%
Bristol-Myers Squibb 70.16 0.78 1.12% 11.14%
ChemoCentryx 51.49 -0.11 -0.21% 233.92%
Coherus Biosciences 10.58 0.06 0.57% -31.25%
Endo International 0.10 -0.01 -5.20% -96.28%
Gilead Sciences 65.28 0.18 0.28% -8.04%
GlaxoSmithKline 1,348.60 4.40 0.33% -5.00%
Horizon Pharma 66.09 4.06 6.55% -38.66%
Intercept Pharmaceuticals 17.00 -0.13 -0.76% 16.04%
Infinity Pharmaceuticals 1.49 -0.02 -1.32% -58.03%
Jazz Pharmaceuticals 152.66 1.11 0.73% 13.41%
J&J 165.71 0.32 0.19% -0.75%
Eli Lilly 317.70 2.20 0.70% 32.65%
Medtronic 89.73 1.84 2.09% -31.58%
Merck & Co 87.34 -0.08 -0.09% 18.91%
Neurocrine Biosciences 106.51 -0.17 -0.16% 10.10%
Novartis 79.36 0.58 0.74% 0.88%
Pacira 55.75 0.12 0.22% 0.63%
Pfizer 47.84 0.76 1.61% 4.94%
Perrigo 39.15 0.55 1.42% -10.39%
Ultragenyx Pharmaceutical 49.24 1.51 3.16% -51.58%
Regeneron Pharmaceuticals 724.32 15.47 2.18% 11.35%
Roche Holding 324.25 0.40 0.12% -5.74%
Revance Therapeutics 28.47 3.17 12.53% 4.98%
Sanofi 81.20 0.64 0.79% -0.82%
Teva Pharmaceutical Industries 9.17 0.17 1.89% -0.22%
UCB 71.10 0.64 0.91% -22.04%
United Therapeutics 223.48 -0.23 -0.10% 6.29%
Vertex Pharmaceuticals 292.11 3.12 1.08% 54.91%
Zoetis 164.31 5.82 3.67% -20.62%

Indexes Price Day Year
US500 4067 61.18 1.53% -8.77%

AbbVie
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.